FIELD: medicine; pharmaceutics; chemistry.
SUBSTANCE: group of inventions relates to pharmaceutics and chemistry. Object 1 is a drug for treating ophthalmia, obtained from dexamethasone sodium phosphate, dexpanthenol, lidocaine hydrochloride, levofloxacin hemihydrate, hydroxypropyl methylcellulose, benzalkonium chloride, polysorbate 80, vitamin E, disodium edetate, glycerol and water. Object 2 is a method of producing a medicinal agent for treating ophthalmia.
EFFECT: providing the possibility of preventing and treating ophthalmia in a low-temperature climate with simultaneous provision of anesthetic, anti-inflammatory, antimicrobial, regenerative and antioxidant action.
2 cl, 2 dwg, 4 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
PHARMACEUTICAL ANTIGLAUCOMA COMPOSITION | 2009 |
|
RU2402316C2 |
EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
EYE DROPS | 2010 |
|
RU2443416C2 |
PHARMACEUTICAL COMPOSITION OF TAFLUPROST | 2021 |
|
RU2761625C2 |
EYE DROPS | 2010 |
|
RU2431470C1 |
OPHTHALMOLOGIC GEL AND METHOD OF ITS PREPARATION | 2007 |
|
RU2340327C1 |
REDUCED DOSAGE OF ANTIBIOTIC IN ANTIBIOTIC/ANTI-INFLAMMATORY AGENT COMPOSITIONS COMBINED FOR OPHTHALMIC USE | 2020 |
|
RU2820235C2 |
EYE DROPS | 2010 |
|
RU2453304C2 |
AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
Authors
Dates
2024-10-04—Published
2022-11-28—Filed